These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2079379)
1. Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs. Wuis EW; Vree TB; Van Der Kleijn E Int J Clin Pharmacol Res; 1990; 10(4):203-10. PubMed ID: 2079379 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of dantrolene in horses. DiMaio Knych HK; Arthur RM; Taylor A; Moeller BC; Stanley SD J Vet Pharmacol Ther; 2011 Jun; 34(3):238-46. PubMed ID: 21492188 [TBL] [Abstract][Full Text] [Related]
3. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of dantrolene sodium in horses. Court MH; Engelking LR; Dodman NH; Anwer MS; Seeler DC; Clark M J Vet Pharmacol Ther; 1987 Sep; 10(3):218-26. PubMed ID: 3656508 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous dantrolene in children. Lerman J; McLeod ME; Strong HA Anesthesiology; 1989 Apr; 70(4):625-9. PubMed ID: 2929999 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of dantrolene and its metabolites, 5-hydroxydantrolene and nitro-reduced acetylated dantrolene (F 490), in plasma and urine of man and dog by high-performance liquid chromatography. Wuis EW; Grutters AC; Vree TB; van der Kleyn E J Chromatogr; 1982 Sep; 231(2):401-9. PubMed ID: 7130316 [TBL] [Abstract][Full Text] [Related]
9. Differences in the pharmacokinetics of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, in rats and dogs. Jinno F; Takeuchi T; Tagawa Y; Kondo T; Itoh T; Asahi S Drug Metab Dispos; 2012 Apr; 40(4):648-54. PubMed ID: 22203697 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses. Nouws JF; Firth EC; Vree TB; Baakman M Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894 [TBL] [Abstract][Full Text] [Related]
13. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog. Cotler S; Chen S; Macasieb T; Colburn WA Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of radiolabelled quinlukast in rats. Syrovatko M; Laznickova A; Laznicek M J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224 [TBL] [Abstract][Full Text] [Related]
15. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830 [TBL] [Abstract][Full Text] [Related]
16. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
18. Disposition of the opioid antagonist, LY255582, in rats and dogs. Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781 [TBL] [Abstract][Full Text] [Related]
19. In vivo metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in rats and dogs: pharmacokinetics, isolation, identification, and quantification of metabolites. Takenaga N; Ishii M; Nakajima S; Hasegawa T; Iwasa R; Ishizaki H; Kamei T Drug Metab Dispos; 1999 Feb; 27(2):205-12. PubMed ID: 9929504 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogs. Wuis EW; Dirks MJ; Termond EF; Vree TB; Van der Kleijn E Int J Clin Pharmacol Res; 1989; 9(4):239-46. PubMed ID: 2777427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]